Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.2 USD | +3.45% |
|
-6.25% | -63.25% |
Jul. 02 | HC Wainwright Trims Price Target on Gain Therapeutics to $8 From $9, Maintains Buy Rating | MT |
Jun. 28 | Sector Update: Health Care Stocks Higher Pre-Bell Friday | MT |
Evolution of the average Target Price on Gain Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Gain Therapeutics, Inc.
HC Wainwright | |
Maxim | |
Chardan Research | |
Oppenheimer | |
BTIG | |
B. Riley |
EPS Revisions
- Stock Market
- Equities
- GANX Stock
- Consensus Gain Therapeutics, Inc.